Northeast Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36,850
Closed -$2.58M 190
2022
Q1
$2.58M Sell
36,850
-10,286
-22% -$752K 0.14% 80
2021
Q4
$3.67M Sell
47,136
-32,766
-41% -$2.89M 0.18% 71
2021
Q3
$7.63M Buy
79,902
+4,113
+5% +$434K 0.41% 48
2021
Q2
$9.42M Buy
75,789
+5,931
+8% +$708K 0.51% 44
2021
Q1
$9.21M Buy
69,858
+1,838
+3% +$252K 0.54% 42
2020
Q4
$9.01M Buy
68,020
+6,177
+10% +$747K 0.55% 41
2020
Q3
$6.3M Buy
61,843
+3,079
+5% +$266K 0.42% 49
2020
Q2
$5.11M Buy
58,764
+5,492
+10% +$439K 0.38% 53
2020
Q1
$3.09M Sell
53,272
-9,896
-16% -$803K 0.28% 66
2019
Q4
$5.84M Buy
63,168
+10,863
+21% +$955K 0.43% 59
2019
Q3
$4.73M Buy
52,305
+851
+2% +$97K 0.38% 61
2019
Q2
$6.07M Buy
51,454
+6,407
+14% +$646K 0.48% 56
2019
Q1
$3.9M Buy
45,047
+6,938
+18% +$591K 0.33% 65
2018
Q4
$2.4M Buy
38,109
+3,998
+12% +$274K 0.23% 72
2018
Q3
$2.69M Buy
34,111
+28,114
+469% +$1.83M 0.22% 74
2018
Q2
$359K Buy
+5,997
New +$323K 0.03% 133

Other funds holding EXAS

Northeast Investment Management's EXAS Position: Q2 2022 in Review

Northeast Investment Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 36,850 shares — an estimated $2.58M sold.

Northeast Investment Management first reported a position in EXAS in Q2 2018 and held it in 16 quarters. The position peaked at $9.42M in Q2 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Northeast Investment Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Northeast Investment Management sold 36,850 Exact Sciences shares in Q2 2022, an estimated $2.58M.
  • Northeast Investment Management first reported a position in Exact Sciences in Q2 2018 and held it in 16 quarters.
  • Northeast Investment Management's Exact Sciences position peaked at $9.42M in Q2 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Northeast Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.